Buy MLTX by Mar 8, 2026.

MoonLake Immunotherapeutics ($MLTX) YOLO. I added on to my position here today. **I still like the stock.** https://preview.redd.it/zc40oltmxz5g1.png?width=1428&format=png&auto=webp&s=a74b691ad738a98051f57bf276544ee1785ba373 TL;DR: MoonLake ($MLTX) is primed to be a chronic inflammatory disease (CID) powerhouse. We have an upcoming FDA Type B meeting on December 15, 2025. This is just the beginning. MoonLake has a shareholder friendly management team and a massive potential addressable market. We already have a robust dataset from various clinical trials on SLK efficacy across various indications in the CID …